Skip to main content

Table 3 Respiratory and haematological dysfunction, ICU monitoring and treatment

From: Characteristics and outcomes of cancer patients in European ICUs

  No cancer
(n = 2674)
Solid tumours
(n = 404)
Haematological cancer
(n = 69)
Mechanical ventilation 1724 (64.5%) 253 (62.6%) 48 (69.6%)
ALI/ARDS 325 (12.2%) 47 (11.6%) 21 (30.4%)$
PaO 2 /FiO 2 202.8 (133.4 to 295.0) 224.0 (144.0 to 324.3) 140.0 (94.0 to 206.2)$
MV, days/patient 3.0 (1.0 to 7.0) 2.0 (1.0 to 6.0) 4.0 (2.0 to 6.0)
Leucopenia 43 (1.6%) 14 (3.5%)* 17 (24.6%)$
Thrombocytopenia 373 (13.9%) 52 (12.9%) 35 (50.7%)$
Pulmonary artery catheter 430 (16.1%) 37 (9.2%)$ 14 (20.3%)
Central venous catheter 1896 (70.9%) 317 (78.5%) 59 (85.5%)
Arterial catheter 1882 (70.4%) 304 (75.2%) 54 (78.3%)$
Vasopressors 1089 (40.7%) 163 (40.3%) 41 (59.4%)*
Inotropes 505 (18.9%) 61 (15.1%) 20 (29.0%)*
Haemofiltration 184 (6.9%) 16 (4.0%) 11 (15.9%)*
Haemodialysis 121 (4.5%) 16 (4.0%) 4 (5.8%)
  1. ALI: acute lung injury; ARDS: acute respiratory distress syndrome; FiO2: inspired fraction of oxygen; ICU = intensive care unit; MV: mechanical ventilation; PaO2: arterial partial pressure of oxygen.
  2. * p < 0.05 versus no-cancer group; $ p < 0.001 versus no-cancer group.
  3. Data are presented as number (percentage) or median (interquartile range)